2X-121 Uses, Dosage, Side Effects and more

2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP).

Trade Name 2X-121
Generic 2X-121
Type
Formula C18H15N5O
Weight Average: 317.352
Monoisotopic: 317.127660123
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share